Sugi Predict

Sugi Predict / Compounds / SCHEMBL10115967

SCHEMBL10115967

SCHEMBL10115967

CC(C)S(=O)(=O)NC1CCN(C(=O)Nc2ccc3c(c2)C(=O)N(c2ccccc2)C3=O)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ MEN1 O00255 3/20 0.51
▸ MAPT P10636 3/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ RXFP1 Q9HBX9 1/20 0.45
▸ POLB P06746 3/20 0.43
▸ HPGD P15428 1/20 0.43
▸ MAPK1 P28482 2/20 0.42
▸ LMNA P02545 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ FAAH O00519 1/20 0.39
▸ HTT P42858 2/20 0.39
▸ HCRTR1 O43613 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ TP53 P04637 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10115965 0.93 ALDH1A1 (0.53) KMT2AALDH1A1MEN1MAPTPOLB
SCHEMBL10115966 0.91 ALDH1A1 (0.43) KMT2AALDH1A1MEN1MAPTPOLB
SCHEMBL10116176 0.88 EPHX2 (0.44) KMT2AALDH1A1MEN1POLBHPGD
SCHEMBL10115934 0.87 ALDH1A1 (0.49) KMT2AALDH1A1MEN1MAPTKDM4E
SCHEMBL12882644 0.87 ALDH1A1 (0.51) KMT2AALDH1A1MEN1MAPTKDM4E
SCHEMBL10115979 0.86 LMNA (0.40) KMT2AALDH1A1MAPTKDM4EPOLB
SCHEMBL10114437 0.86 ALDH1A1 (0.54) KMT2AALDH1A1MEN1MAPTKDM4E
SCHEMBL10115980 0.83 ALDH1A1 (0.58) KMT2AALDH1A1MEN1MAPTKDM4E
SCHEMBL10115849 0.81 ALDH1A1 (0.55) KMT2AALDH1A1KDM4EPOLBLMNA
SCHEMBL12882650 0.80 PANK3 (0.44) KMT2AALDH1A1MEN1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-20110039802-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2011-02-17 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015762-A1 NPY Y5 antagonist NPY5R, NPY1R, NPY2R KMT2A 2912/4885ALDH1A1 4558/4885MEN1 2876/4885
US-20100292500-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R KMT2A 2768/4885ALDH1A1 4599/4885MEN1 2932/4885
US-20110039802-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R KMT2A 2953/4885ALDH1A1 4517/4885MEN1 2926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.